Trial Profile

Impact of CardiolRxTM on Recurrent Pericarditis An Open Label Pilot Study (MAvERIC-Pilot Study)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Sep 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cannabidiol (Primary)
Indications Pericarditis
Focus Therapeutic Use
Acronyms MAvERIC-Pilot Study
Sponsors Cardiol Therapeutics

Most Recent Events

07 May 2026 According to a Cardiol Therapeutics media release, results from this study have been accepted for publication in a forthcoming issue of the Journal of the American Heart Association
18 Nov 2024 Results presented at the American Heart Association Scientific Sessions 2024
12 Sep 2024 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com